Evaluation of epratuzumab as a biologic therapy in systemic lupus erythematosus. (2014)
Attributed to:
Centre for Musculoskeletal Ageing Research
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2217/imt.14.80
PubMed Identifier: 25496332
Publication URI: http://europepmc.org/abstract/MED/25496332
Type: Journal Article/Review
Volume: 6
Parent Publication: Immunotherapy
Issue: 11
ISSN: 1750-743X